What does APOTHEEK MOENS NIEL do?

APOTHEEK MOENS NIEL is a pharmacy in Niel. Public Limited, started on 15 January 1998, 1 establishment.

What is the address of APOTHEEK MOENS NIEL?

The registered office of APOTHEEK MOENS NIEL is located at Heideplaats 42, 2845 Niel.

Is APOTHEEK MOENS NIEL still active?

Yes. According to the CBE (30 October 2026) APOTHEEK MOENS NIEL is active, legal situation “Normale toestand”, started on 15 January 1998.

Is APOTHEEK MOENS NIEL registered on Peppol?

Yes, APOTHEEK MOENS NIEL is registered on the Peppol network with ID 0208:0462414044.

What is the enterprise number of APOTHEEK MOENS NIEL?

The enterprise number of APOTHEEK MOENS NIEL is BE0462414044.

When was APOTHEEK MOENS NIEL founded?

APOTHEEK MOENS NIEL was founded on 15 January 1998.

Who are the directors of APOTHEEK MOENS NIEL?

According to the 2025 annual accounts, the directors of APOTHEEK MOENS NIEL are: Fimovar NV.

Is APOTHEEK MOENS NIEL a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 15 January 1998; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did APOTHEEK MOENS NIEL make in 2025?

APOTHEEK MOENS NIEL posted a profit after taxes of € 160,429 in financial year 2025.

What is the revenue of APOTHEEK MOENS NIEL?

As a small company, APOTHEEK MOENS NIEL is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 560,140.

How much does an employee at APOTHEEK MOENS NIEL earn?

The average wage cost per full-time employee at APOTHEEK MOENS NIEL was € 73,100 in 2025: staff costs of € 153,426 for 2.1 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTHEEK MOENS NIEL have?

According to the 2025 annual accounts, APOTHEEK MOENS NIEL has 2.1 full-time equivalents (FTE).

APOTHEEK MOENS NIEL (Public Limited) - Niel

Dossier APOTHEEK MOENS NIEL, printed on 30 October 2026 from databakkes.be/en/0462414044/apotheek-moens-niel. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTHEEK MOENS NIEL from Niel, company number BE0462414044, closed financial year 2025 with a result of € 160,429 after tax. For that financial year APOTHEEK MOENS NIEL recorded a gross margin of € 560,140 and equity of € 96,215. Compared with financial year 2024, the result moved from € 180,868 to € 160,429. The company is profitable. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 29, 2026.

What it is worth Growing

€ 96,215

▲ 6% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 160,429

▼ 11% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 12,149

▼ 26% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 155,000 paid out

97 % of the profit went to the shareholders, mostly to FIMOVAR (99 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

2.1

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 153,426

▲ 20% vs 2024

€ 73,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 32,500

▲ € 26,762 vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 1 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 170,829

▼ 46% vs 2024

€ 33,304 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.

Owed to suppliers

€ 828,894

▼ 13% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 50,628

▲ 47% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 396,308 Gross margin 2022: € 396,308 First fiscal year in the series	€ 401,229 Gross margin 2023: € 401,229 ▲ 1% vs 2022 (€ 396,308) Favourable step	€ 526,374 Gross margin 2024: € 526,374 ▲ 31% vs 2023 (€ 401,229) Favourable step	€ 560,140 Gross margin 2025: € 560,140 ▲ 6% vs 2024 (€ 526,374) Favourable step	▲ 6%
Profit after taxes	€ 51,501 Profit after taxes 2022: € 51,501 First fiscal year in the series	€ 76,716 Profit after taxes 2023: € 76,716 ▲ 49% vs 2022 (€ 51,501) Favourable step	€ 180,868 Profit after taxes 2024: € 180,868 ▲ 136% vs 2023 (€ 76,716) Favourable step	€ 160,429 Profit after taxes 2025: € 160,429 ▼ 11% vs 2024 (€ 180,868) Unfavourable step	▼ 11%
Equity	€ 158,202 Equity 2022: € 158,202 First fiscal year in the series	€ 84,918 Equity 2023: € 84,918 ▼ 46% vs 2022 (€ 158,202) Unfavourable step	€ 90,786 Equity 2024: € 90,786 ▲ 7% vs 2023 (€ 84,918) Favourable step	€ 96,215 Equity 2025: € 96,215 ▲ 6% vs 2024 (€ 90,786) Favourable step	▲ 6%
Total debts	€ 959,962 Total debts 2022: € 959,962 First fiscal year in the series	€ 1,255,672 Total debts 2023: € 1,255,672 ▲ 31% vs 2022 (€ 959,962) Unfavourable step	€ 1,480,304 Total debts 2024: € 1,480,304 ▲ 18% vs 2023 (€ 1,255,672) Unfavourable step	€ 1,205,351 Total debts 2025: € 1,205,351 ▼ 19% vs 2024 (€ 1,480,304) Favourable step	▼ 19%
Cash	€ 40,239 Cash 2022: € 40,239 First fiscal year in the series	€ 36,526 Cash 2023: € 36,526 ▼ 9% vs 2022 (€ 40,239) Unfavourable step	€ 16,379 Cash 2024: € 16,379 ▼ 55% vs 2023 (€ 36,526) Unfavourable step	€ 12,149 Cash 2025: € 12,149 ▼ 26% vs 2024 (€ 16,379) Unfavourable step	▼ 26%
Land & buildings	€ 9,277 Land & buildings 2022: € 9,277 First fiscal year in the series	€ 8,562 Land & buildings 2023: € 8,562 ▼ 8% vs 2022 (€ 9,277) Unchanged	€ 36,357 Land & buildings 2024: € 36,357 ▲ € 27,795 vs 2023 (€ 8,562) Unchanged	€ 32,731 Land & buildings 2025: € 32,731 ▼ 10% vs 2024 (€ 36,357) Unchanged	▼ 10%
Retained profit	€ 96,229 Retained profit 2022: € 96,229 First fiscal year in the series	€ 22,945 Retained profit 2023: € 22,945 ▼ 76% vs 2022 (€ 96,229) Unfavourable step	€ 28,813 Retained profit 2024: € 28,813 ▲ 26% vs 2023 (€ 22,945) Favourable step	€ 34,242 Retained profit 2025: € 34,242 ▲ 19% vs 2024 (€ 28,813) Favourable step	▲ 19%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 150,000 Dividend 2023: € 150,000 Unchanged (€ 0) Unchanged	€ 175,000 Dividend 2024: € 175,000 ▲ 17% vs 2023 (€ 150,000) Unchanged	€ 155,000 Dividend 2025: € 155,000 ▼ 11% vs 2024 (€ 175,000) Unchanged	▼ 11%
Bank debt	€ 360,148 Bank debt 2022: € 360,148 First fiscal year in the series	€ 370,276 Bank debt 2023: € 370,276 ▲ 3% vs 2022 (€ 360,148) Unfavourable step	€ 314,566 Bank debt 2024: € 314,566 ▼ 15% vs 2023 (€ 370,276) Favourable step	€ 170,829 Bank debt 2025: € 170,829 ▼ 46% vs 2024 (€ 314,566) Favourable step	▼ 46%
Balance sheet total	€ 1,118,165 Balance sheet total 2022: € 1,118,165 First fiscal year in the series	€ 1,340,590 Balance sheet total 2023: € 1,340,590 ▲ 20% vs 2022 (€ 1,118,165) Unchanged	€ 1,571,090 Balance sheet total 2024: € 1,571,090 ▲ 17% vs 2023 (€ 1,340,590) Unchanged	€ 1,301,567 Balance sheet total 2025: € 1,301,567 ▼ 17% vs 2024 (€ 1,571,090) Unchanged	▼ 17%
Employees (FTE)	2.3 Employees (FTE) 2022: 2.3 First fiscal year in the series	1.9 Employees (FTE) 2023: 1.9 ▼ 0.4 vs 2022 (2.3) Unchanged	2.1 Employees (FTE) 2024: 2.1 ▲ 0.2 vs 2023 (1.9) Unchanged	2.1 Employees (FTE) 2025: 2.1 Unchanged (2.1) Unchanged

Key figures of APOTHEEK MOENS NIEL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK MOENS NIEL?

What happened at APOTHEEK MOENS NIEL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 29, 2026 New annual accounts for financial year 2025: profit of € 160,429 (▼ 11% vs 2024). Source: NBB ↗
2023 Fimovar NV became a director. NBB
Jun 3, 1998 New establishment in Niel. KBO
Jan 15, 1998 Start of the company according to the CBE. KBO

In short

From € 51,501 profit in 2022 to € 160,429 profit in 2025.

Paid € 173,553 in corporate taxes since 2022.

Best year ever: 2024, with € 180,868 profit.

On average € 266,700 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

FIMOVAR 99.2%

The stake of FIMOVAR comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK MOENS NIEL

Behind APOTHEEK MOENS NIEL is Fimovar NV. The shares are held by FIMOVAR (99.2%).

Directors

According to the 2025 annual accounts

Fimovar NV

Bestuurder · represented by Filip Moens

Also active at: APOTHEEK MOENS MORTSEL, Apotheek MOENS-MAMPAEY

since 2023

Shareholders

FIMOVAR

99.2%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Heideplaats 42

2845 Niel

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

FIMOVAR same network

€ 338,725 gross margin · 2025

Groep Fimovar

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0462.414.044

VAT number

BE 0462.414.044

Registered office

Heideplaats 42, 2845 Niel

Names & denominations

APOTHEEK MOENS NIEL

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

15 January 1998

Peppol

Active · Active since 15 Apr 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK MOENS NIEL

Financials

What happened to APOTHEEK MOENS NIEL?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions